Study at a glance
What question did the studies ask?
Researchers asked which proteins work with the vitamin D receptor and how strong the evidence is. The receptor is a protein that responds to active vitamin D. Studies used human and rat cell models, isolated protein parts and mice. Some cell models came from cancers. These were not clinical treatment trials.
What did the researchers find?
Some experiments found direct binding between isolated protein parts. Others found proteins together in cell extracts or at related DNA regions. DNA carries genetic information. Finding proteins at the same DNA region does not prove that they directly bind each other.
Changing a gene or protein supported particular changes in gene activity. Many proposed connections between gene-regulating proteins were not fully tested. A mouse blood-vessel study used toxic injected vitamin D3 doses and produced harmful mineral deposits. It does not predict ordinary supplement effects. In another mouse experiment, a receptor unable to bind hormone normally still preserved selected hair-cycle functions. Receptor loss is different from low vitamin D supply.
What does this mean?
Some experiments used calcitriol, the active vitamin D hormone. Others used a laboratory-made receptor activator with a separate substance limiting another protein’s action. These exposures differ from oral vitamin D3. The studies support specific partnerships with important limits. They do not establish that the same set of proteins always improves function or that every tissue effect comes from one contact between two proteins. They do not provide a personal treatment dose.
Read the full article below ↓Several proteins can cooperate with the vitamin D receptor, but different tests provide different strengths of evidence. Finding proteins together, finding them near the same DNA region and showing direct binding are not the same result. This summary explains those distinctions and their limits. For the detailed evidence, read Vitamin D Receptor Partners and Regulatory Networks: Full Evidence Review.
What are the researchers trying to establish?
The vitamin D receptor is a protein responding to active vitamin D. Vitamin D Receptors explains the receptor, and Vitamin D and Nuclear Receptors places it within its wider family. Other proteins help control which genes are used. The broader question is introduced in Vitamin D and Transcription Factors. DNA carries genetic information; gene activity is explained in Vitamin D and Gene Expression.
A predicted DNA sequence is a possible binding site, not proof of binding. Finding proteins together in a cell extract can show association without proving direct contact. Tests with isolated protein parts can investigate direct binding, but do not by themselves establish how that contact works in a whole tissue. Changing a protein can test whether it contributes to a response.
What did the experiments show?
A human immune-cell model grown from a blood cancer produced a predicted network of gene-regulating proteins. Among two selected example factors, binding was examined for both, but only one was selectively reduced to test its contribution. Many predicted connections remained untested. Reducing the tested factor caused some responses to disappear, others to appear and others to remain. [1]
A kidney-scarring study included direct binding between isolated protein parts and interference with a regulator’s ability to bind DNA. Liver-cell experiments instead measured related DNA-binding patterns and responses to changing the regulatory proteins. Both provide useful evidence, but they do not establish one identical mechanism in every tissue. [2] [3]
Another study examined changes between groups of proteins that alter how DNA is packaged. It combined a laboratory-made receptor activator with a separate substance limiting another protein’s action. Insulin is a hormone that helps regulate blood sugar. Selected blood-sugar and insulin findings in mice did not establish an ordinary vitamin D3 treatment for people. They also did not prove that one protein contact caused all the effects. [4]
In rat cells that can mature into myelin-producing cells, receptor association and tests reducing receptor function supported a role in maturation. Myelin insulates nerve fibres. The extra response to calcitriol, the active vitamin D hormone, depended on laboratory conditions. The specific contact between the receptor pair was not isolated as the sole cause. [5]
A mouse blood-vessel study linked regulatory cooperation with harmful mineral deposits under toxic injected vitamin D3 exposure. Cooperation therefore does not automatically mean benefit. A separate mouse hair-cycle experiment found that a receptor unable to bind hormone normally still preserved selected functions. Receptor loss is not the same as low vitamin D supply, and this did not show that every skin function is independent of hormone binding. [6] [7]
A separate study used human colon cells grown as three-dimensional cultures to examine a DNA-sequence difference near POLB, a gene involved in DNA repair. Tests of gene control and receptor binding supported a regulatory role for that DNA region. A gene message could rise without a protein rise at the same time. The researchers did not edit the sequence in its original position to prove that it caused every response. They did not demonstrate better DNA repair or cancer prevention, or establish POLB as a physical partner of the receptor. [8]
What can be concluded?
Some partnerships have substantial support from protein and cell experiments. Many proposed network connections are less certain, and a binding test is not automatically proof of a tissue outcome. The findings depend on which cells and DNA regions were tested, which receptor form was present and which other signals were active. They do not establish that oral vitamin D3 reproduces every laboratory response or provide a personal treatment dose.
Scientific sources
[1] A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick T, Schulz MH, Günther S, Gilsbach R, Neme A, Carlberg C, Brandes RP, Seuter S. Scientific reports. 2021;11(1):6518. DOI 10.1038/s41598-021-86032-5; PMID 33753848; PMCID PMC7985518.
[2] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.
[3] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.
[4] Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell. 2018;173(5):1135-1149.e15. DOI 10.1016/j.cell.2018.04.013; PMID 29754817; PMCID PMC5987229.
[5] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. de la Fuente AG, Errea O, van Wijngaarden P, Gonzalez GA, Kerninon C, Jarjour AA, Lewis HJ, Jones CA, Nait-Oumesmar B, Zhao C, Huang JK, ffrench-Constant C, Franklin RJ. The Journal of cell biology. 2015;211(5):975-985. DOI 10.1083/jcb.201505119; PMID 26644513; PMCID PMC4674280.
[6] Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. PloS one. 2013;8(12):e83584. DOI 10.1371/journal.pone.0083584; PMID 24349534; PMCID PMC3861528.
[7] Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.). 2005;19(4):855-862. DOI 10.1210/me.2004-0415; PMID 15591533.
[8] Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB. Witonsky D, Laxman B, Usman H, Bielski MC, Lawrence KM, Kupfer SS. PLoS genetics. 2026;22(1):e1011983. DOI 10.1371/journal.pgen.1011983; PMID 41505470; PMCID PMC12810902.
Related reading
Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials
We searched PubMed, Embase, and the Cochrane Library for the time period through June 2017 to identify randomized controlled trials that evaluated paricalcitol compared with other VDRAs for treatment of SHPT.
Original paper ↗Read more →The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways in Chronic Lymphocytic Leukemia
To this end, we investigated whether the calcitriol/VDR system is functional in CLL and analyzed key signaling pathways that are regulated by calcitriol supplementation, while also exploring the role of microenvironmental signals in the regulation of calcitriol/VDR system.
Original paper ↗Read more →Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact Matching
Future randomized clinical trials with a sufficient sample size and an adequate follow-up period are warranted to test the clinical effectiveness of VDRA on infection and malignancy, rather than cardiovascular disease, among dialysis patients.
Original paper ↗Read more →Vitamin D, the Vitamin D Receptor, Calcitriol Analogues and Their Link with Ocular Diseases
However, as these studies have some limitations, we recommend further randomized trials to clarify the link between vitamin D and its activity with eye disease.
Original paper ↗Read more →A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes
The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).
Original paper ↗Read more →Functional Cooperation between Vitamin D Receptor and Runx2 in Vitamin D-Induced Vascular Calcification
The transdifferentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells has been implicated in the context of vascular calcification.
Original paper ↗Read more →Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB
In our study, we aimed to understand how active vitamin D affects colon cells from people with African and European backgrounds.
Original paper ↗Read more →Vitamin D Receptor Partners and Regulatory Networks: Full Evidence Review
Assess vitamin D receptor cooperation through purified binding, genomic cooccupancy, chromatin complexes and network perturbations, with causal limits.
Read more →Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation
Vitamin D receptor (VDR) is present in multiple blood cells, and the hormonal form of vitamin D, 1,25-dihydroxyvitamin D (1,25D) is essential for the proper functioning of the immune system.
Original paper ↗Read more →1,25-Dihydroxyvitamin D and the Vitamin D Receptor Gene Polymorphism Apa1 Influence Bone Mineral Density in Primary Hyperparathyroidism
Randomized, prospective studies are necessary to elucidate whether vitamin D supplementation additionally increases serum 1,25(OH)2D and possibly enhances the adverse effects on the skeleton in patients with PHPT.
Original paper ↗Read more →1,25-Dihydroxyvitamin D Induces a NURR1-Tyrosine Hydroxylase Transcriptional Axis Modulated by Rexinoid/RXR Signaling in Parkinson’s Disease-Relevant Human Neural Cell Models
Tyrosine hydroxylase (TH) encodes a neuronally expressed enzyme that catalyzes the initial, rate-limiting step in the production of several catecholamine neurotransmitters and hormones, including dopamine, norepinephrine, and epinephrine.
Original paper ↗Read more →Effect of Calcitriol and Vitamin D Receptor Modulator 2 on Recovery of Injured Skeletal Muscle in Wistar Rats
Muscle injuries often result in functional limitations due to insufficient healing.
Original paper ↗Read more →Stop codon readthrough generates a C-terminally extended variant of the human vitamin D receptor with reduced calcitriol response
Extending on the identification of this readthrough motif, we here investigated stop codon readthrough, using tissue culture reporter assays, for all previously untested human genes containing UGA_CUAG.
Original paper ↗Read more →The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism
The present study evaluated the efficacy of calcitriol treatment in NAFLD patients with regard to the vitamin D receptor (VDR) genotypes of FokI polymorphism.
Original paper ↗Read more →TGF-β1 stimulation and VDR-dependent activation modulate calcitriol action on skeletal muscle fibroblasts and Smad signalling-associated fibrogenesis
Herein, the effects of calcitriol on cultured skeletal muscle primary fibroblasts of male C57BL/6 mice (aged 1 month old) were investigated.
Original paper ↗Read more →Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach
The aim of the present study was to determine if calcitriol induces ERα expression in ER-negative breast cancer cells, thus restoring antiestrogen responses.
Original paper ↗Read more →Calcitriol restrains microglial M1 polarization and alleviates dopaminergic degeneration in hemiparkinsonian mice by boosting regulatory T‐cell expansion
In this study, we investigated the therapeutic effects of vitamin D receptor activation by calcitriol on PD, specifically focusing on its role in Treg.
Original paper ↗Read more →1,25-Dihydroxyvitamin D Deficiency Accelerates Aging-related Osteoarthritis via Downregulation of Sirt1 in Mice
Emerging observational data suggest that vitamin D deficiency is associated with the onset and progression of knee osteoarthritis (OA).
Original paper ↗Read more →Calcitriol affects hCG gene transcription in cultured human syncytiotrophoblasts
In pregnancy, maternal serum concentrations of calcitriol significantly rise as a result of increased renal and placental contribution in order to assure calcium supply for the developing fetus.
Original paper ↗Read more →Effect of exogenous calcitriol on myopia development and axial length in guinea pigs with form deprivation myopia
Our study investigated the effect of calcitriol role in myopia by inducing the condition in guinea pigs through form deprivation for four weeks.
Original paper ↗Read more →Vitamin D Receptors
A physiology-first explanation of vitamin D receptors, covering cellular detection, transcriptional regulation, signalling integration, and tissue-specific responsiveness.
Read more →Original sources
A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes
The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).
Publication details
[1] A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick T, Schulz MH, Günther S, Gilsbach R, Neme A, Carlberg C, Brandes RP, Seuter S. Scientific reports. 2021;11(1):6518. DOI 10.1038/s41598-021-86032-5; PMID 33753848; PMCID PMC7985518.
A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
[2] A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
Publication details
[2] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
[3] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
Publication details
[3] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.
Vitamin D Switches BAF Complexes to Protect β Cells.
[4] Vitamin D Switches BAF Complexes to Protect β Cells.
Publication details
[4] Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell. 2018;173(5):1135-1149.e15. DOI 10.1016/j.cell.2018.04.013; PMID 29754817; PMCID PMC5987229.
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
[5] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
Publication details
[5] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. de la Fuente AG, Errea O, van Wijngaarden P, Gonzalez GA, Kerninon C, Jarjour AA, Lewis HJ, Jones CA, Nait-Oumesmar B, Zhao C, Huang JK, ffrench-Constant C, Franklin RJ. The Journal of cell biology. 2015;211(5):975-985. DOI 10.1083/jcb.201505119; PMID 26644513; PMCID PMC4674280.
Functional Cooperation between Vitamin D Receptor and Runx2 in Vitamin D-Induced Vascular Calcification
The transdifferentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells has been implicated in the context of vascular calcification.
Publication details
[6] Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. PloS one. 2013;8(12):e83584. DOI 10.1371/journal.pone.0083584; PMID 24349534; PMCID PMC3861528.
Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis.
Published in Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.) (2005).
Publication details
[7] Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.). 2005;19(4):855-862. DOI 10.1210/me.2004-0415; PMID 15591533.
Genomic profiling of active vitamin D colonic responses in African- and European-Americans identifies an ancestry-related regulatory variant of POLB
In our study, we aimed to understand how active vitamin D affects colon cells from people with African and European backgrounds.
Publication details
[8] Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB. Witonsky D, Laxman B, Usman H, Bielski MC, Lawrence KM, Kupfer SS. PLoS genetics. 2026;22(1):e1011983. DOI 10.1371/journal.pgen.1011983; PMID 41505470; PMCID PMC12810902.